Market Signal Briefing

Journalist

Posted: October 27, 2025

Key Takeaways
How has Pudgy Penguins’ official coin performed recently?
Since August, it has shown bearish tendencies, with the second half of September seeing PENGU retrace by 33% in a week. 

What should traders and investors expect next for PENGU?
A move past $0.027 would be an early sign of a shift towards bullish strength.

The Pudgy Penguins [PENGU] token has rallied by 9% in 24 hours. This shift in short-term bullish sentiment came as Bitcoin [BTC] posted a 3.3% move higher to $115k while Ethereum [ETH] climbed by 7% in the same period.

The Pudgy Penguins NFT sales saw a dramatic pick-up in volume over the past month. The sales volume was particularly heavy just after the liquidation event on 10 October. The floor price fell from 10 ETH to 7.21 ETH as well.

The PENGU token has also shown bearish dominance since mid-August, after ceding the $0.032-support level. However, with its rally in June to $0.046 in mind, its swing structure has remained bullish.

Negative sentiment and steady selling hamper PENGU bulls
The weighted sentiment has been negative since late July. It hinted at bearish social media engagement, and any positive mentions had too little volume and not enough consistency to shift the trend.

The Open Interest has also been sinking for the most part since early August. Together, the two metrics highlighted bearish sentiment in social media posts related to PENGU and a lack of confidence in the derivatives market.

The selling was especially strong over the past month. The $0.03-support had been key in August and September, but was breached in October and the area retested as a supply zone. In October, the Coin Days Destroyed metric saw several sizeable peaks.

These peaks accompanied PENGU setting new lows and underlined persistent on-chain selling.

Source: PENGU/USDT on TradingView

Finally, the Fibonacci retracement levels captured the bullish swing structure of PENGU. However, the series of lower highs and lower lows since August highlighted the bearish trend of PENGU in recent weeks.

The CMF has not shown heavy, consistent selling pressure despite the downtrend. This may be a small spark of hope for bulls hoping for a turnaround in PENGU’s price fortunes.

The $0.027 is a key resistance to overcome, to flip the internal structure bullishly.

Akashnath S is a Senior Journalist and Technical Analysis expert at AMBCrypto. He specializes in dissecting price action, identifying key market trends through advanced chart patterns, and forecasting both short-term and long-term asset trajectories.
His distinct analytical method is grounded in his academic training as a Chemical Engineer. This background provides him with a systematic, process-oriented approach to market data, enabling him to analyze the complex dynamics of financial markets with precision and objectivity.
Having actively covered the cryptocurrency space since the landmark 2017 market cycle, Akashnath possesses years of experience navigating both bull and bear markets. This seasoned perspective is critical to his insightful reporting on market volatility and evolution.
As an active market participant, Akashnath enhances his analysis with crucial, hands-on experience. This practical application of his technical skills ensures his insights are not merely theoretical, but are also relevant and actionable for an audience looking to understand and navigate trading opportunities. He is dedicated to educating readers on the nuances of technical analysis, empowering them with the knowledge to make more informed financial decisions.

1 hour ago

The Crypto Fear & Greed Index has flipped to neutral, leaving “fear” behind for the first time since the mid-October market crash sparked by Trump’s China tariffs.

886

The Crypto Fear & Greed Index finally clawed its way out of the “fear” zone on Sunday, resolving to neutral for the first time in more than two weeks as the price of Bitcoin surged back to around $115,000 over the weekend.

The Crypto Fear & Greed Index, which measures overall market sentiment, is currently sitting in the “neutral” zone with a score of 51 out of 100.  

It’s up 11 points from the fearful score of 40 on Saturday, and also up over 20 points since last week, marking a sharp change in tune over the past few days.       

The current Crypto Fear and Greed score. Source: Alternative.me  Trump’s China tariff announcement on Oct. 10 had plunged the index from a “greed” score of 71 to a yearly low of 24 as $19 billion of crypto leveraged positions were liquidated. 

“Aggressive” BTC selling is waningThe shift in sentiment comes amid a recent decline in Bitcoin (BTC) selling pressure, according to Bitcoin analytics platform Glassnode.

In an X post on Sunday, Glassnode suggested a trend reversal is in the works, as selling pressure and negative sentiment appear to have already peaked to their extremes.   

“For the first time since the October 10th flush, spot and futures CVD [Cumulative Volume Delta] have flattened, indicating that aggressive selling pressure has subsided over the last several days,” the post reads, adding:

“Funding rates remain below the neutral level of 0.01%, indicating no excessive long positioning or froth. In fact, we can see that funding flipped very negative several times over the last 2 weeks showing that participants lean towards caution.”Glassnode’s Bitcoin data breakdown. Source: Glassnode
Looking ahead at other potentially bullish indicators, the market is seemingly anticipating another interest rate cut by the US Federal Reserve at its Oct. 29 meeting.

At the time of writing, data from CME Group’s FedWatch tips a 96.7% chance that the Fed will cut rates by a quarter of a percentage point this week. 

Magazine: Bitcoin flashing ‘rare’ top signal, Hayes tips $1M BTC: Hodler’s Digest, Oct. 19 – 25

The crypto market today is witnessing explosive momentum as Bitcoin surges past the $115,000 mark, reigniting bullish sentiment across the board. Major altcoins like VIRTUAL, ZEC & DASH are skyrocketing, reflecting renewed investor confidence and growing market liquidity ahead of a high-volatility week. With traders eyeing key macro events and technical breakouts, the digital asset space is buzzing with optimism. The big question now—can this rally be sustained, or is the market gearing up for another round of sharp corrections?

Virtual Protocol (VIRTUAL) Price Breaks Bearish PatternOver the past few months, the Virtual Protocol price has been stuck within a descending parallel channel. The token attempted a breakout that resulted in forming yet another lower high, indicating the rising strength of the bears. However, it has broken above the structure following a strong influx of buying volume that suggests the VIRTUAL price is poised for a strong upswing. 

The price broke above the channel with a huge rise in the buying pressure; however, the technicals point towards a consolidation ahead of the next breakout. The RSI entered the overbought range and appears to be flattening. On the other hand, On-Balance Volume spiked and continues to maintain a steady rise. Flattening RSI & rising OBV is usually a bullish signal, hinting towards accumulation during consolidation. It implies that smart money is quietly buying regardless of price movement and creating bullish pressure beneath the surface. 

Therefore, traders can expect a cooling phase before breaking the resistance zone between $1.86 and $1.94 that may pave the way beyond $2 to reach $2.1. 

Zcash (ZEC) Price Eyes 35% Rise to Hit $500Zcash price is witnessing one of the bulliest months, not seen in the past few years. The buying volume rose back to the 2021 bull run days, which helped the price mark a steep rise after following a prolonged ascending consolidation. Currently, the ZEC price has surpassed one of the important resistances, which was the market top during the 2021 bull run. If the price sustains within the range, a continued upswing may help the price break higher targets. 

As seen in the above chart, the ZEC price has broken the resistance zone between $293 and $316 and closed the weekly trade above this range. This suggests the bulls have held a tight grip over the rally, and the momentum may not fade as OBV remains escalated. Interestingly, the 50/200 weekly MA underwent a bullish crossover that could help the token sustain the upward trend and push towards the higher targets at 1.2 FIB at $471 and 1.4 FIB at $522. 

Regardless of the 20% Jump Dash (DASH) Price Awaits a BreakoutEver since the rally rose above the impact of the 2022 bear market, the DASH price has been stuck within a massive descending parallel channel. Every attempt of the token to break the resistance has resulted in a strong rejection, while the current scenario raises some hopes. The price has been defending the pivotal support just above $40 for a few weeks and hence flashes a huge possibility of a breakout above $60 in the coming days. 

The DASH price remains within the descending parallel channel but has secured the pivotal support at the 200-day MA. With the volume spiking to the highest levels not seen in recent times, a breakout from the range could be imminent. On the other hand, the RSI has yet again entered the overbought range. Previously, this move followed a steep rejection, but the current rebound suggests there could be more room for the price to rise. Therefore, once the RSI reenters back into the overbought range, the price could break the channel and rise above the resistance zone between $61 and $63. 

Once these levels are secured, the Dash price may enter a strong bullish trend and probably reach $100 in 2025.

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

Solana started a fresh increase above the $200 zone. SOL price is now consolidating above $200 and might aim for more gains above the $208 zone.

SOL price started a fresh upward move above the $188 and $195 levels against the US Dollar.
The price is now trading above $200 and the 100-hourly simple moving average.
There is a bullish trend line forming with support at $198 on the hourly chart of the SOL/USD pair (data source from Kraken).
The pair could extend gains if it clears the $208 resistance zone.

Solana Price Jumps Again Above $200
Solana price started a decent increase after it settled above the $180 zone, like Bitcoin and Ethereum. SOL climbed above the $188 level to enter a short-term positive zone.

The price even smashed the $198 resistance. The bulls were able to push the price above $200. The price is now consolidating gains above the 23.6% Fib retracement level of the recent upward move from the $177 swing low to the $204 high.

Solana is now trading above $200 and the 100-hourly simple moving average. Besides, there is a bullish trend line forming with support at $198 on the hourly chart of the SOL/USD pair.

Source: SOLUSD on TradingView.com
On the upside, the price is facing resistance near the $205. The next major resistance is near the $208 level. The main resistance could be $212. A successful close above the $212 resistance zone could set the pace for another steady increase. The next key resistance is $225. Any more gains might send the price toward the $232 level.

Another Pullback In SOL?
If SOL fails to rise above the $205 resistance, it could start another decline. Initial support on the downside is near the $198 zone and the trend line. The first major support is near the $192 level and the 50% Fib retracement level of the recent upward move from the $177 swing low to the $204 high.

A break below the $192 level might send the price toward the $184 support zone. If there is a close below the $184 support, the price could decline toward the $180 support in the near term.

Technical Indicators

Hourly MACD – The MACD for SOL/USD is gaining pace in the bullish zone.

Hourly Hours RSI (Relative Strength Index) – The RSI for SOL/USD is above the 50 level.

Major Support Levels – $198 and $184.

Major Resistance Levels – $205 and $208.

Journalist

Posted: October 27, 2025

Key Takeaways
Who’s driving Ethereum’s momentum?
Addresses holding 10K–100K ETH expanded holdings to 31 million, matching whale patterns seen before past bull runs.

What confirms growing confidence?
36.15M ETH staked and a positive Fund Market Premium near $3.9K signaled firm institutional sentiment.

Ethereum [ETH] recovered strongly after the recent market turmoil that drained capital from the crypto market. The altcoin, once down to $3,988, surged 7% in 24 hours to trade near $4,200.

An AMBCrypto analysis suggests that demand continues to build, with ETH’s latest rally reinforcing its path toward a potential new all-time high. Here’s how.

Accumulators take charge again
Data from Alphractal showed that addresses holding 10K–100K ETH have expanded their holdings since April, now near a record 31 million ETH.

Historically, similar accumulation phases preceded major bull runs in 2017 and 2021, when ETH hit $1,419 and $4,867, respectively.

Source: Alphractal

This latest uptick highlights the same cohort’s growing influence as ETH extends its rally beyond the $4,000 mark.

On top of that, other market segments appear to be mirroring this bullish accumulation trend.

Staking strengthens ETH’s floor
The odds in favor of a strong ETH rally remain high. One key indicator supporting this outlook is the Total Value of Staked Ethereum.

Interestingly, the data showed that the total amount of Ethereum staked in the market reached 36.15 million in the past day, nearly matching the amount purchased by the accumulation group.

Staked ETH is crucial because it represents tokens removed from active circulation; a continued rise in staking generally signals increasing confidence and reduced sell pressure, both of which strengthen the asset’s position in the market.

Source: CryptoQuant

Similarly, Ethereum Exchange Reserves remained flat over the past day. Data from CryptoQuant showed that only about 15.9 million ETH remain in exchange reserves, suggesting limited selling pressure and stronger holding sentiment.

With a 7% rally in the past 24 hours and ETH trading around $4,200, renewed institutional inflows could trigger the next upward leg.

Institutional sentiment remains firm
CryptoQuant’s Fund Market Premium stayed in positive territory despite brief corrections, signaling persistent institutional interest.

Historically, when this premium held above 0, ETH prices trended upward within subsequent weeks.

Source: CryptoQuant

That same setup pointed to renewed institutional conviction even as short-term volatility remains elevated.

Cumulatively, Ethereum’s whales, stakers, and funds remain aligned for a medium-term bullish continuation, with momentum strengthening above $4,200 as long as macro tailwinds persist.

In brief
India's Madras High Court ruled Friday that crypto constitutes property protected under constitutional law, blocking WazirX from reallocating user assets under its Singapore restructuring plan.
Justice N. Anand Venkatesh granted an injunction protecting 3,532 XRP tokens, rejecting the exchange's "socialization of losses" scheme following the July 2024 hack that drained $234 million.
The ruling "strengthens consumer protection for crypto-holders and paves the way for clearer regulatory frameworks," though India still lacks comprehensive oversight, experts told Decrypt.
XRP holders scored a victory in India after a court ruled that cryptocurrencies qualify as property under law, marking one of the country’s clearest legal acknowledgments of digital asset ownership.

The Madras High Court on Friday barred WazirX, India’s largest crypto exchange, from redistributing a customer’s 3,532 XRP holdings to offset losses from a $234 million hack that hit the platform in July last year.

Justice N. Anand Venkatesh said the user’s XRP tokens, purchased in January and unaffected by the incident, could not be diluted under the exchange’s “socialization of losses” plan.

“It is not a tangible property nor is it a currency,” Justice Venkatesh wrote. “However, it is a property, which is capable of being enjoyed and possessed in a beneficial form.”

The decision grants legal standing to crypto assets as property capable of ownership and protection under Indian law. It also establishes that assets held in custody by exchanges must be treated as client property held in trust.

"This clarity is very helpful: it strengthens consumer protection for crypto-holders, affirms their rights as asset owners, and paves the way for clearer regulatory and fiduciary frameworks in the crypto ecosystem in India," Sudhakar Lakshmanaraja, founder of Digital South Trust, told Decrypt.

Justice Venkatesh noted the applicant had “used the WazirX platform through her mobile phone from her ordinary place of residence and was prevented from trading or liquidating her holdings,” establishing that crypto assets accessed within India fall under Indian court protection.

“Together, these judgments stand among the first major Indian court decisions on cryptocurrency issues: they are foundational 'crypto-jurisprudence,’” Vikram Subburaj, CEO of Indian crypto exchange Giottus, told Decrypt.

“For all participants (exchanges, users, regulators), these are signals that the high-tech arena will be held to high standards of governance and protection,” Subburaj added.

Not your XRPThe court rejected WazirX's "socialization of losses" plan—a proposal to spread the $234 million proportionally across all users—that the judge compared to "a group insurance of a self-help group." 

“The basis of such a proposition is not any term in the contractual framework between the parties," making it unenforceable against Indian users, Justice Venkatesh ruled.

The judge also rejected WazirX's argument that its Singapore court-approved restructuring automatically binds Indian users. 

The ruling adds to a growing body of Indian crypto jurisprudence that defines user protections amid the government’s slow regulatory progress. The case follows a Bombay High Court decision rejecting similar loss-sharing measures by Bitcipher Labs.

It also arrived on the same day that WazirX restarted operations, with 95.7% creditor approval. 

Users have so far reported receiving only 30% of expected funds amid locked accounts and customer verification delays.

Crypto policy remains lopsided—strict on revenue collection with a 30% levy and 1% TDS, but silent on investor rights or asset ownership rules.

"Ultimately, courts have become the central stage where the future of digital value is debated," the judge wrote. "Through each ruling, they are shaping a clearer picture of rights, responsibilities, and trust in the age of decentralization." 

WazirX did not immediately return Decrypt's request for comment.

Daily Debrief NewsletterStart every day with the top news stories right now, plus original features, a podcast, videos and more.

Mon, 27/10/2025 - 6:13

Short-run marginal emissions might overstate how dirty Bitcoin mining actually is, according to a new study

Cover image via U.Today

Bitcoin advocate Daniel Batten has once again taken aim at The New York Times for peddling “junk science” in order to prop up its anti-Bitcoin narrative.

"Well, the bitcoin maxis were right (again)," Batten said in a recent social media post.

Flawed methodology Batten is referring to The New York Times article that was criticizing Bitcoin mining for its excessive energy consumption. 

HOT Stories

However, as the Bitcoin advocate points out, the methodology that the controversial article relied on is inherently flawed, given that it relied on marginal emission calculations.

Remember that NYTimes hitpiece on Bitcoin mining and how we said it was junk science but no one believed us? Well, the bitcoin maxis were right (again)

The way NYTimes incorrectly applied Marginal Emissions to advance their case has now been debunked in peer reviewed study pic.twitter.com/5vR2NlTwGU

— Daniel Batten (@DSBatten) October 27, 2025 Marginal emissions represent extra emissions that are created by consuming an additional unit of electricity.

A recent peer-reviewed study in Nature Climate Change shows that such an approach can actually overestimate the impact of emissions since electricity systems are dynamic. 

The study, which uses rooftop solar as an example, shows that emission savings tend to be smaller due to daytime rooftop solar replacing other clean energy sources before fossil fuels. 

You Might Also Like

Batten applies the same logic to Bitcoin. The CO₂ impact of mining Bitcoin is likely to be much smaller, and not every extra MWh consumed by miners is fossil-fuel-heavy. 

The outdated methodology does not take into account curtailed renewable generation as well as clean energy investment.

According to the most recent Cambridge study, the share of sustainable energy sources (nuclear, wind, and hydropower) for Bitcoin has grown to 52.4%. 

Related articles

Bitcoin (BTC) has surged past the 50-day simple moving average (SMA), signaling renewed short-term bullish momentum. The cryptocurrency is currently trading at $115,465.30, reflecting increased investor optimism driven by expectations of a possible Federal Reserve rate cut and easing tensions in the U.S.-China trade dispute.

Technical indicators reinforce this positive sentiment. The daily MACD histogram shows a fresh bullish crossover, while a 5- and 10-day SMA crossover suggests growing upward pressure. These signals typically indicate that traders are regaining confidence in Bitcoin’s near-term outlook.

Despite the encouraging momentum, analysts urge caution. The CoinDesk Bitcoin Trend Indicator (BTI) continues to register a downtrend, hinting that bearish sentiment may still linger beneath the surface. Additionally, Bitcoin remains below the Ichimoku cloud on the daily chart — a significant resistance zone that must be broken to confirm a sustained bullish reversal.

A decisive breakout above the Ichimoku cloud could open the path toward $120,000 and higher, marking a major shift in market structure. Until then, traders are watching closely for confirmation signals that validate this emerging trend.

Market watchers attribute Bitcoin’s recent upswing to growing expectations that the Federal Reserve may cut interest rates in its upcoming policy meeting this Wednesday. Lower rates often stimulate risk appetite, driving capital flows into alternative assets like Bitcoin. Moreover, signs of progress in the U.S.-China trade negotiations are improving global market sentiment, providing additional support to crypto assets.

While the technical outlook leans bullish, traders are reminded to monitor key resistance levels and remain vigilant for potential pullbacks as Bitcoin navigates a crucial phase in its market cycle.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>

Buyers dominate the cryptocurrency market today as digital currencies extend weekend gains. The Fear and Greed Index has turned neutral after hitting extreme levels early last week. Amidst the optimism, Mantra Chain announced a strategic integration with interoperability network Hyperlane.

ZEC's price has surged by 380% this month.Updated Oct 27, 2025, 6:24 a.m. Published Oct 27, 2025, 6:23 a.m.

Privacy-focused cryptocurrency ZEC$354.99 has recently surged in price, prompting multiple blockchains to integrate the token into their ecosystems.

On Oct. 16, Solana, the world's second-largest smart contract platform, launched wrapped ZEC via the Zolana bridge. However, these wrapped tokens function as standard Solana Program Library (SPL) tokens and do not offer the privacy protections inherent to native Zcash. They are backed 1:1 by native ZEC but do not conceal balances or transaction data.

Encifher addresses this limitation by re-wrapping tokens into encrypted assets like eZEC, enabling private, encrypted swaps on Solana through cutting-edge fully homomorphic encryption (FHE). This technology ensures that sensitive transaction information remains concealed, restoring ZEC’s native privacy on the fast Solana network.

"To truly make ZEC private on Solana, it should be re-wrapped into encrypted assets like eZEC, where balances and transfers are hidden, yet composable with Solana DeFi. That’s how ZEC’s original vision, privacy at the asset level, can actually live on Solana," Encifher's social media handle Encrypto.trade said in a post on X.

Encifher uses powerful encryption to conceal user balances and transfer details on-chain. Transactions are secured and validated through zero-knowledge proofs, while sensitive data remains accessible only to authorized parties using threshold decryption protocols.

This approach encrypts client balances with threshold ElGamal encryption and stores the encrypted data off-chain in a secure data availability layer, while the Solana blockchain handles cryptographic pointers to these balances without exposing the actual values.

Think of EIGama encryption as a treasure chest that opens only when a certain number of trusted friends come together with their own special keys. This means that no single friend can access the chest alone, ensuring added security.

The setup allows users to hold and transfer encrypted ZEC tokens confidentially, effectively transforming Solana’s public blockchain into a privacy-preserving environment that remains fully compatible with decentralized finance applications. The system prevents transaction linkability and address reuse by employing ephemeral accounts that exist for only one transaction lifecycle, making analysis by third parties effectively impossible.

So, with Encifher, Solana users gain a means to reclaim ZEC’s original promise of asset-level privacy on a blockchain known for speed and low cost, bridging the best of both worlds.

Encifher's privacy-preserving features have been implemented on top of Jupiter, Solana's leading decentralized exchange, enabling users to trade encrypted tokens while preserving their privacy.

ZEC's price has surged 380% to $375 this month, CoinDesk data show. Per some observers, the sharp rally has been catalyzed by the impending ZEC halving, the debut of Grayscale ZEC Trust and Hyperliquid listing.

AI Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.

More For You

Stablecoin payment volumes have grown to $19.4B year-to-date in 2025. OwlTing aims to capture this market by developing payment infrastructure that processes transactions in seconds for fractions of a cent.

View Full Report

More For You

Japan's New Yen Stablecoin is Asia’s Only Truly Global Fiat-Pegged Token

With the yen freely convertible and backed by Japan’s deep government bond market, JPYC’s launch stands apart from the region’s onshore-only experiments in Korea, Taiwan, and beyond.

What to know:

Japan has launched the world's first yen-pegged stablecoin, backed by domestic deposits and Japanese government bonds.The yen's convertibility and global use distinguish it from other Asian currencies like the Korean won and Taiwan dollar, which face restrictions.The yen stablecoin could facilitate a USD/JPY market on decentralized platforms, potentially forming the backbone of Asian crypto settlements.Read full story

Rumble, one of the fastest-growing video-streaming platforms, is taking a major step toward merging digital finance with online content creation. In collaboration with Tether, the company behind USDT and XAUT, Rumble plans to roll out a crypto tipping feature that will allow users to reward their favorite creators using Bitcoin (BTC), Tether (USDT), and Tether Gold (XAUT).

In brief
Zcash has drawn renewed speculative attention ahead of its November halving, with traders positioning around the privacy coin narrative.
Endorsements from prominent investors and revived privacy debates have fueled market activity despite limited on-chain growth, Decrypt was told.
The rally’s sustainability hinges on post-halving sentiment and whether user adoption can extend beyond short-term speculation, one expert said.
Zcash has blasted past its 2021 peak after a 30-day triple-digit rally, driven by the convergence of speculative hype and a renewed focus on privacy.

Zcash has climbed from a low of $54 to around $372 in a month, positioning it as one of the market's top performers. 

That's 11.5% higher than the May 8, 2021, high of $319. The asset is still down 88% from its all-time high of $3,191.93 set nearly nine years ago, according to CoinGecko data.

The market’s underlying volatility and bullish sentiment were reflected in predictions market Myriad, owned by Decrypt’s parent company DASTAN, where the chance of Zcash hitting $369 was resolved after the token hit a high of $374.4 on Sunday.

Zcash’s rise can be attributed to a “perfect storm of catalysts,” including the upcoming November halving, renewed interest in privacy coins amid rising surveillance concerns, and a viral $10,000 price call from Arthur Hayes, Shivam Thakral, CEO of BuyUCoin, told Decrypt.

The halving is expected to slash the miner's block reward by half, from 3.125 to 1.5625 ZEC, on November 18. 

Drivers that initially triggered a volatile breakout in the first week of October included endorsements from prominent investors like Naval Ravikanth and ex-Coinbase engineer and Helius CEO Mert Mumtaz.

Grayscale’s decision to allow eligible investors to gain exposure to the ZEC token has helped push the token’s uptrend in the second half of this month, Decrypt previously reported.

Renewed interest in privacy tokens has also lifted the broader sector, with Monero and Dash gaining 9.1% and 12.5%, respectively, over the past week as traders rotate into older, anonymity-focused assets.

"Privacy is back in focus," as global regulations tighten and digital surveillance debates heat up, Thakral added. "Zcash, despite being an older coin, offers a clear, simple privacy narrative, and with its halving near, traders found an easy, liquid way to express that theme."

Still, Thakral cautioned that the rally appears to be driven more by speculation than fundamental growth, citing a limited increase in “shielded transactions.”

The next leg hinges on how miners and investors react post-halving and on whether the privacy narrative can sustain real user growth beyond pure speculation and trigger a sell-the-news reversal, Thakral said.

Daily Debrief NewsletterStart every day with the top news stories right now, plus original features, a podcast, videos and more.

Ethereum co-founder Vitalik Buterin and Solana co-founder Anatoly Yakovenko have ignited debate within the crypto community over the true security of Ethereum’s layer-2 (L2) networks. The discussion highlights key differences in how each blockchain approaches scalability and trust.

Buterin reaffirmed that Ethereum’s L2 solutions—such as Arbitrum, Base, Optimism, and Worldchain—derive their security directly from Ethereum’s base layer. He stressed that even a 51% attack cannot validate fraudulent blocks or compromise user assets. According to him, L2s inherit Ethereum’s consensus and finality, ensuring strong protection against network manipulation. However, he warned that if validators are trusted with actions beyond the blockchain’s control, this assurance weakens, allowing potential collusion or errors to undermine system integrity.

Yakovenko, however, rejected the idea that Ethereum’s L2s inherit full Ethereum-level security. In a post on X, he argued, “The claim that L2s inherit ETH security is erroneous.” He contended that five years into Ethereum’s L2 roadmap, these solutions still share similar risks with wrapped assets on Solana bridges. Yakovenko pointed to fundamental issues such as complex codebases that increase attack surfaces, multisig custody risks where collusion could compromise funds, and off-chain processing that introduces centralization.

He further proposed building a specialized Ethereum–Solana bridge, positioning Ethereum as a layer-2 to Solana—an idea aimed at merging scalability with enhanced cross-chain security.

According to L2Beat, Ethereum now hosts over 129 verified L2 networks holding more than $35 billion in total value locked. Yet, as the ecosystem expands, critics question whether the surge of L2s fosters innovation or adds inefficiencies. Despite Ethereum’s one million validators compared to Solana’s 2,000, the debate underscores a crucial industry challenge: balancing scalability, decentralization, and security in the evolving blockchain landscape.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>

, /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Health Canada has issued a Notice of Compliance with Conditions (NOC/c) for Leqembi® (lecanemab) for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment or mild dementia due to Alzheimer's disease (early AD) who are apolipoprotein E ε4 (ApoE ε41) non-carriers or heterozygotes and who have confirmed amyloid pathology. LEQEMBI is the first treatment for early AD that targets an underlying cause of the disease, to be authorized in Canada.

Leqembi selectively binds to soluble Aβ aggregates (protofibrilsi), as well as insoluble Aβ aggregates (fibrils) which are a major component of Aβ plaques, thereby reducing both Aβ protofibrils and Aβ plaques in the brain. Leqembi is the first approved treatment shown to reduce the rate of disease progression and to slow cognitive and functional decline in adults with Alzheimer's disease. Leqembi is approved in 51 countries and regions including Japan, the United States, Europe, China, South Korea, Taiwan, and Saudi Arabia, and applications have been filed in 9 countries.

The approval of Leqembi is based on the large global Phase 3 Clarity AD study. In the Clarity AD study, Leqembi met its primary endpoint and all key secondary endpoints with statistically significant results.2,3 Leqembi has been issued market authorization in Canada with conditions, pending the results of trials to verify its clinical benefit. Eisai plans to submit clinical assessment data captured from participants in real-world clinical practice.

Alzheimer's Disease is the most common form of dementia, accounting for 60 to 80% of all cases.4 As of January 1, 2025, it is estimated there are more than 771,000 patients with dementia in Canada, which is expected to increase to approximately 1 million in 2030 and over 1.7 million in 2050.5 In addition, annual care provided by family and friends for those with dementia is equivalent to 290,000 full-time jobs, which is expected to increase to 690,000 full-time jobs in 2050.5 

Leqembi is the result of a long-standing collaboration between BioArctic and Eisai, and the antibody was originally developed by BioArctic based on the work of Professor Lars Lannfelt and his discovery of the Arctic mutation in Alzheimer's disease. Eisai is responsible for the clinical development, applications for market approval and commercialization of Leqembi for Alzheimer's disease. BioArctic has the right to commercialize Leqembi in the Nordic region together with Eisai and the two companies are preparing for a joint commercialization in the region.

The information was released for public disclosure, through the agency of the contact person below, on October 27, 2025, at 00:35 a.m. CET

For further information, please contact: 
Oskar Bosson, Vice President Communications and Investor Relations
Telephone: +46 70 410 71 80
E-mail: [email protected]

About lecanemab (Leqembi ® )
Lecanemab is the result of a strategic research alliance between BioArctic and Eisai. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ).

Lecanemab is approved in the U.S., Japan, EU, China, Great Britain, and several other markets for the treatment of mild cognitive impairment (MCI) due to Alzheimer's disease (AD) and mild AD dementia. Lecanemab's approvals in these countries, as well as the EC's market authorization, were primarily based on Phase 3 data from Eisai's global Clarity AD clinical trial, a Phase 3 global, placebo-controlled, double-blind, parallel-group, randomized study in 1,795 patients with early AD (MCI or mild dementia due to AD, with confirmed presence of amyloid pathology), in which it met its primary endpoint and all key secondary endpoints with statistically significant results. The treatment group was administered lecanemab 10 mg/kg bi-weekly, with participants allocated in a 1:1 ratio to receive either placebo or lecanemab for 18 months.6

Lecanemab is approved in 51 countries including the U.S., Japan, China, and the European Union for the treatment of Alzheimer's disease (AD) in patients with Mild Cognitive Impairment (MCI) or mild dementia stage of disease (collectively referred to as early AD) and is under regulatory review in 9 countries. Following the initial phase with treatment every two weeks for 18 months, intravenous (IV) maintenance dosing with treatment every four weeks is approved in China, the U.S. and others, and applications have been filed in 9 countries and regions. Leqembi Iqlik™ is approved for subcutaneous injection for maintenance dosing for the treatment of early Alzheimer's disease in the US. In September 2025, a rolling sBLA application for the subcutaneous initiation dosing with Leqembi Iqlik was also initiated to the U.S. FDA.

Since July 2020, Eisai's Phase 3 clinical study (AHEAD 3-45) with lecanemab in individuals with preclinical AD, meaning they are clinically normal and have intermediate or elevated levels of amyloid in their brains, is ongoing. The study was fully recruited in October 2024. AHEAD 3-45 is a four-year study conducted as a public-private partnership between Eisai, Biogen and the Alzheimer's Clinical Trial Consortium that provides the infrastructure for academic clinical trials in AD and related dementias in the U.S, funded by the National Institute on Aging, part of the National Institutes of Health. Since January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy.

About the collaboration between BioArctic and Eisai
Since 2005, BioArctic has a long-term collaboration with Eisai regarding the development and commercialization of drugs for the treatment of Alzheimer's disease. The most important agreements are the Development and Commercialization Agreement for the lecanemab antibody, which was signed 2007, and the Development and Commercialization agreement for the antibody Leqembi back-up for Alzheimer's disease, which was signed 2015. In 2014, Eisai and Biogen entered into a joint development and commercialization agreement for lecanemab. Eisai is responsible for the clinical development, application for market approval and commercialization of the products for Alzheimer's disease. BioArctic has the right to commercialize lecanemab in the Nordic region and is currently preparing for commercialization in the Nordics together with Eisai. BioArctic has no development costs for lecanemab in Alzheimer's disease and is entitled to payments in connection with regulatory approvals, and sales milestones as well as royalties on global sales.

About BioArctic AB
BioArctic AB (publ) is a Swedish research-based biopharma company focusing on innovative treatments that can delay or stop the progression of neurodegenerative diseases. The company invented Leqembi® (lecanemab) – the world's first drug proven to slow the progression of the disease and reduce cognitive impairment in early Alzheimer's disease. Leqembi has been developed together with BioArctic's partner Eisai, who are responsible for regulatory interactions and commercialization globally. In addition to Leqembi, BioArctic has a broad research portfolio with antibodies against Parkinson's disease and ALS as well as additional projects against Alzheimer's disease. Several of the projects utilize the company's proprietary BrainTransporter™ technology, which has the potential to actively transport antibodies across the blood-brain barrier to enhance the efficacy of the treatment. BioArctic's B share (BIOA B) is listed on Nasdaq Stockholm Large Cap. For further information, please visit www.bioarctic.com.

1 Apolipoprotein E is a protein involved in the metabolism of lipid in humans. It is implicated in AD. People with only one (heterozygous) or no copy (non-carriers) of the ApoE ε4 gene are less likely to experience ARIA than people with two ApoE ε4 copies (homozygous). ARIA is a recognized important side effect with lecanemab that involves swelling and potential bleeding in the brain.

2 Eisai presents full results of lecanemab Phase 3 confirmatory Clarity AD study for early Alzheimer's disease at Clinical Trials on Alzheimer's Disease (CTAD) conference. Available at: https://www.eisai.co.jp/news/2022/news202285.html 

3 van Dyck, H., et al. Lecanemab in Early Alzheimer's Disease. New England Journal of Medicine. 2023;388:9-21. https://www.nejm.org/doi/full/10.1056/NEJMoa2212948.

4 Alzheimer Society of Canada "What is Alzheimer's disease?". Available at: https://alzheimer.ca/en/about-dementia/what-alzheimers-disease Last accessed: June 2025.

5 Alzheimer Society of Canada "Dementia numbers in Canada". Available at: https://alzheimer.ca/en/about-dementia/what-dementia/dementia-numbers-canada Last accessed: June 2025.

6 van Dyck, C.H., et al. Lecanemab in Early Alzheimer's Disease. New England Journal of Medicine. 2023;388:9-21. https://www.nejm.org/doi/full/10.1056/NEJMoa2212948

i Protofibrils are believed to contribute to the brain injury that occurs with AD and are considered to be the most toxic form of Aβ, having a primary role in the cognitive decline associated with this progressive, debilitating condition. Protofibrils cause injury to neurons in the brain, which in turn, can negatively impact cognitive function via multiple mechanisms, not only increasing the development of insoluble Aβ plaques but also increasing direct damage to brain cell membranes and the connections that transmit signals between nerve cells or nerve cells and other cells. It is believed the reduction of protofibrils may prevent the progression of AD by reducing damage to neurons in the brain and cognitive dysfunction.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/bioarctic/r/health-canada-grants-authorization-for-leqembi---lecanemab-,c4256844

The following files are available for download:

SOURCE BioArctic

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

Analyst’s Disclosure:I/we have a beneficial long position in the shares of AMZN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

SummarySyndax Pharmaceuticals received expanded FDA approval for Revuforj, tripling its addressable AML patient population despite a boxed safety warning.Revumenib remains the only FDA-approved menin inhibitor for both KMT2A-rearranged and NPM1-mutated AML, offering a defensible niche and first-mover advantage.SNDX trades at a premium valuation, reflecting high expectations for commercial ramp; strong cash reserves support future trials and launches.Key risks include boxed warnings for differentiation syndrome and QTc prolongation, with commercial execution and physician adoption critical for future growth.wildpixel/iStock via Getty Images

Thesis Yesterday, Syndax Pharmaceuticals (NASDAQ:SNDX) again got the nod from the FDA for its leukaemia treatment Revuforj. Now, this is actually an extended approval, so the drug is now eligible for a wider array of patients. I will clarify

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Silgan Holdings (SLGN) is upgraded from 'sell' to 'hold' as revenue and profits rebound after a challenging 2023. SLGN's growth is driven by the Weener Packaging acquisition, strong Dispensing and Specialty Closures segment, and ongoing cost-cutting initiatives. Management expects continued top- and bottom-line growth, with adjusted EPS and cash flow projected to rise in the upcoming quarter.

Sheridan's hits for Paramount include “Tulsa King” and “Landman.” In addition to TV shows, he will make movies for NBCUniversal.

Technology is one of the most exciting sectors in the stock market because of its disruptive nature. But despite excellent growth potential, things don't always work out. New materials and techniques often take years or decades to break into the mainstream because of cost challenges and lack of scale compared to legacy systems, leaving early movers struggling to turn a profit despite their innovations.

Cutting-edge semiconductor company Wolfspeed (WOLF 0.07%) is an excellent example of this phenomenon. The company chronically underperformed before completing a Chapter 11 bankruptcy restructuring in late September. But is this a new beginning, or another round of long-term disappointment? Let's dig deeper to find out.

Today's Change

(

-0.07

%) $

-0.02

Current Price

$

29.57

A new beginning for Wolfspeed?
With shares up by over 2,000% since emerging from bankruptcy, Wolfspeed looks like a clear winner. However, the devil is in the details. The good news is that the restructuring agreement eliminated a whopping 70% of the company's $6.6 billion mountain of debt -- reducing annual interest expense by 60% and kicking debt maturities all the way back to 2030. However, this deal came at a significant cost to shareholders.

According to Reuters, the deal cancelled Wolfspeed's legacy shares and reissued just 1.3 million shares to existing shareholders -- an exchange ratio of less than 1% per old share. Most of the new equity will go to the company's creditors, such as Apollo Global Management and other banks.

While the deal may seem unfair, equity holders are typically the biggest losers in bankruptcy proceedings (because debt holders have a higher priority). And in this case, Wolfspeed's old shareholders are lucky to have gotten anything at all. Furthermore, the deal gives the company a new beginning where it can pioneer its exciting semiconductor technology and benefit from having large, powerful owners that may be willing to provide much-needed financial support in the future.

At the right place at the right time
Wolfspeed's restructuring deal is actually a vote of confidence in its business model and technology. The company specializes in making silicon carbide (SiC) chips -- a type of semiconductor device capable of handling higher voltages and temperatures than traditional alternatives. These characteristics make the technology ideal for next-generation applications like electric vehicles (EVs) and solar power electronics.

Image source: Getty Images.

Wolfspeed is unique because of its vertically integrated process, where it designs and produces its devices internally (through a network of U.S. facilities) instead of outsourcing the heavy lifting to foreign companies. The company's "made in America" approach has put it at the right place at the right time to benefit from political efforts to bolster advanced chip manufacturing in the U.S. amid rising geopolitical tensions with China.

In 2024, Wolfspeed secured $750 million in funding from the Biden-era CHIPS Act (although the grant hasn't been delivered yet). And while the Trump administration has taken less interest in green technology, it has also introduced a variety of tax breaks and incentives for domestic manufacturing as part of its recently passed One Big Beautiful Bill Act.

So what's the catch?
From a bird's-eye view, Wolfspeed looks like a clear winner. It is pioneering cutting-edge semiconductor technology with significant government support. Meanwhile, the recent bankruptcy deal has cleaned up its balance sheet while giving it powerful new owners. However, none of these advantages matter if the company can't make money.

Fiscal fourth-quarter earnings show clear challenges, with revenue dropping 2% year over year to $197 million, while operating losses ballooned from $148.9 million to $581.6 million. Wolfspeed's challenges could potentially worsen as the loss of U.S. electric vehicle tax credits hurts some of its top customers. Investors should stay far away for now.

Both Starbucks and Coca-Cola rang in the decade paying $0.41 per share in dividends, and each has an identical 2.9% dividend yield today. Even so, Coca-Cola outshines Starbucks as an income investment, on three crucial fundamentals.

A sign stands outside Chinese drugmaker Innovent Biologics' office in Shanghai, China July 11, 2025. REUTERS/Andrew Silver Purchase Licensing Rights, opens new tab

CompaniesSHANGHAI, Oct 27 (Reuters) - China's Innovent Biologics

(1801.HK), opens new tabsaid, opens new tabon Monday its GLP-1 injection led to more weight loss and better control of blood sugar in patients with diabetes than injectable semaglutide, the active ingredient in Novo Nordisk's

(NOVOb.CO), opens new tab diabetes and weight-loss medicines.

The late-stage head-to-head trial compared different doses of the two drugs in patients with diabetes and obesity to assess glycemic control and weight loss. One group received a 6 mg dose of the mazdutide drug that Innovent develops and the other a 1 mg dose of injectable semaglutide.

Sign up here.

Innovent, which secured exclusive development and commercialisation rights in China for mazdutide from Eli Lilly

(LLY.N), opens new tab under undisclosed financial terms in 2019, is also approved in China to sell that drug as a treatment for type 2 diabetes.

It is one of a number of Chinese weight loss and diabetes drugmakers ramping up

competition with Novo and Lilly, opens new tab in the world's second-largest pharmaceutical market.

Novo sells injectable semaglutide for patients with type 2 diabetes in China under the brand name Ozempic to control blood sugar.

In the trial, which enrolled 349 adults with type 2 diabetes and obesity, mazdutide showed greater improvements in both HbA1C - a measure of blood sugar over time - and weight reduction.

Patients who took Innovent's drug at the 6 mg dose lost a mean of 10.29% of their weight from baseline compared to 6% with the 1 mg dose of injectable semaglutide. Innovent's drug also lowered patients' HbA1C by a mean of 2.03, compared to 1.84 for the 1 mg dose of injectable semaglutide.

"The head-to-head DREAMS-3 study comparing mazdutide with semaglutide further showed that in patients with T2D and comorbid obesity mazdutide provides superior efficacy in both weight loss and glucose lowering," Innovent's chief R&D officer of general biomedicine, Lei Qian, said in a statement.

A Novo Nordisk spokesperson did not immediately respond to a request for comment sent outside of normal business hours.

Reporting by Andrew Silver in Shanghai; Editing by Muralikumar Anantharaman

Our Standards: The Thomson Reuters Trust Principles., opens new tab

October 27, 2025 1:00 AM EDT | Source: HIVE Digital Technologies Ltd.
This news release constitutes a "designated news release" for the purposes of the Company's amended and restated prospectus supplement dated May 14, 2025, to its short form base shelf prospectus dated September 11, 2024.

San Antonio, Texas--(Newsfile Corp. - October 27, 2025) - HIVE Digital Technologies Ltd. (TSXV: HIVE) (NASDAQ: HIVE) (FSE: YO0) (the "Company" or "HIVE"), a global leader in sustainable digital infrastructure, is pleased to announce it has surpassed 22 Exahash per second ("EH/s") in global Bitcoin-mining capacity — marking 267% year-to-date growth — while accelerating the conversion of Tier-1 data centers into Tier-3 high-performance computing ("HPC") facilities to expand its AI Cloud footprint in Sweden.

HIVE Achieves Major Mining Milestone

HIVE's 22 EH/s milestone reflects the successful expansion of its hydro-powered Valenzuela facility in Paraguay, the Company's third 100-megawatt green campus in the country. The site draws renewable energy from the Itaipu Dam, one of the world's largest hydroelectric sources.

Current production has reached 9.5 Bitcoin per day with fleet efficiency of approximately 17.8 Joules per Terahash ("J/TH") and a 55% mining margin* after electricity costs at $47 Hashprice, demonstrating HIVE's operational efficiency across multiple countries and nine time zones.

With additional ASIC miners coming online, HIVE expects to reach 25 EH/s by U.S. Thanksgiving, targeting fleet efficiency of 17.5 J/TH. Management reports EH/s growth as material to revenue and cash-flow expansion, noting that digital-infrastructure companies are typically valued at multiples of revenue and cash flow.

Accelerating AI Cloud Expansion in Sweden

HIVE is expanding its European AI Cloud operations by converting an existing Tier-1 data center in Boden, Sweden, into a Tier-3 liquid-cooled HPC facility — a strategy that provides a faster path to cash flow, typically 9 months versus 3 years for a greenfield build.

Engineering and design are complete, with construction commencing this quarter. The upgraded facility will deliver a robust critical load, supporting 2,000 NVIDIA GPUs for enterprise-grade AI and GPU cloud workloads across the European Union.

This expansion builds on HIVE's AI operations in downtown Stockholm, active for the past two years, which have served early enterprise clients and validated demand for green, low-latency compute in Northern Europe.

Together with the BUZZ data center in Toronto—which will host an additional 2,000 GPUs in 2026—and planned growth in New Brunswick, HIVE has secured power and land at three strategic locations for next-generation, renewable-powered HPC operations.

Through its colocation partnership with Bell Canada, HIVE's BUZZ division can rapidly deploy AI Cloud GPU infrastructure, enabling flexible scaling to meet enterprise demand. Across its global pipeline, HIVE expects to operate approximately 6,000 GPUs by 2026, serving both AI training and inference workloads.

Executive Commentary

Frank Holmes, Co-Founder and Executive Chairman, stated: "Crossing 22 EH/s marks another major milestone for HIVE as we build one of the world's most efficient and sustainable Bitcoin-mining fleets. At the same time, our AI strategy accelerates the conversion of Tier-1 data centers into Tier-3 HPC facilities, positioning HIVE as a dual-engine digital-power company that bridges blockchain and the AI super cycle."

Mr. Holmes continued: "It is now widely recognized that Bitcoin miners were the original builders of Tier-1 digital-infrastructure networks—developing substations, fiber connectivity, and energy-optimization systems that laid the foundation for today's hyperscale AI data centers. This model is now being replicated globally, including in West Texas, where projects such as Stargate, a US $500 billion HPC campus, mirror the pioneering work of early Bitcoin-mining companies that sourced stranded or surplus renewable energy."

Aydin Kilic, President & CEO, added: "Repurposing existing infrastructure allows HIVE to reach cash-flow generation much faster than greenfield projects. Our operational strength enables us to grow both Bitcoin mining and AI Cloud services in parallel, all powered by renewable energy."

Johanna Thornblad, Sweden Country President, commented: "The Boden expansion reinforces Sweden's leadership in sustainable digital infrastructure. Building on our two years of AI operations in Stockholm, this conversion project will deliver enterprise-grade AI capacity to the EU market faster and more efficiently than traditional data-center builds."

Outlook and Funding

All hardware for HIVE's Paraguay expansion is fully funded and delivered, supported by fixed-rate hydroelectric power ensuring predictable, scalable economics. The Company continues to model robust annual recurring revenue (ARR) potential from both Bitcoin production and AI Cloud contracts, consistent with non-GAAP industry standards.

HIVE targets 25 EH/s by late 2025 and 35 EH/s during 2026, while scaling its HPC division five-fold over the same period.

* As used herein, "Mining Margin" is calculated by dividing the mining profit (revenue generated from mining activities minus power costs related to those activities) by the total revenue generated from mining activities and expressed as a percentage. In mining, the most significant expense is power cost;, in this estimate we are assuming an average of USD 5 cents per kilowatt hour for indicative purposes. "ARR", as a metric, represents revenue only, and does not represent profitability. ARR is presented here as a measure of growth. These non-GAAP measures should be read in conjunction with and should not be viewed as alternatives to or replacements for measures of operating results and liquidity presented in accordance with GAAP in HIVE's quarterly and annual financial statements. All financial projections reflect current market sentiment and public disclosures as of September 2025; actual outcomes may vary. Investors should conduct their own due diligence.

About HIVE Digital Technologies Ltd.

Founded in 2017, HIVE Digital Technologies Ltd. is the first publicly listed company to mine digital assets powered exclusively by green energy. Today, HIVE builds and operates next-generation blockchain and AI data centers across Canada, Sweden, and Paraguay, serving both Bitcoin and high-performance computing (HPC) clients. HIVE's twin-turbo engine infrastructure—driven by Bitcoin mining and NVIDIA GPU-accelerated AI computing—delivers scalable, environmentally responsible solutions for the digital economy.

For more information, visit hivedigitaltech.com, or connect with us on:

X: https://x.com/HIVEDigitalTech
YouTube: https://www.youtube.com/@HIVEDigitalTech
Instagram: https://www.instagram.com/hivedigitaltechnologies/
LinkedIn: https://linkedin.com/company/hiveblockchain

On Behalf of HIVE Digital Technologies Ltd.

"Frank Holmes"
Executive Chairman

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Forward-Looking Information

Except for the statements of historical fact, this news release contains "forward-looking information" within the meaning of the applicable Canadian and United States securities legislation and regulations that is based on expectations, estimates and projections as at the date of this news release. "Forward-looking information" in this news release includes but is not limited to: the performance of the Comp[any's existing operations, the construction of the Company's Phase 3 facility in Valenzuela, Paraguay and its potential specifications and performance upon completion, the timing of it becoming operational; business goals and objectives of the Company; the acquisition, deployment and optimization of the mining fleet and equipment; the continued viability of its existing Bitcoin mining operations; and other forward-looking information concerning the intentions, plans and future actions of the parties to the transactions described herein and the terms thereon.

Factors that could cause actual results to differ materially from those described in such forward-looking information include, but are not limited to: the inability to complete the construction of the Paraguay acquisition on an economic and timely basis and achieve the desired operational performance; the ongoing support and cooperation of local authorities and the Government of Paraguay; the volatility of the digital currency market; the Company's ability to successfully mine digital currency; the Company may not be able to profitably liquidate its current digital currency inventory as required, or at all; a material decline in digital currency prices may have a significant negative impact on the Company's operations; the regulatory environment for cryptocurrency in Canada, the United States and the countries where our mining facilities are located; economic dependence on regulated terms of service and electricity rates; the speculative and competitive nature of the technology sector; dependency on continued growth in blockchain and cryptocurrency usage; lawsuits and other legal proceedings and challenges; government regulations; the global economic climate; dilution; future capital needs and uncertainty of additional financing, including the Company's ability to utilize the Company's ATM Program and the prices at which the Company may sell Common Shares in the ATM Program, as well as capital market conditions in general; risks relating to the strategy of maintaining and increasing Bitcoin holdings and the impact of depreciating Bitcoin prices on working capital; the competitive nature of the industry; currency exchange risks; the need for the Company to manage its planned growth and expansion; the need for continued technology change; the ability to maintain reliable and economical sources of power to run its cryptocurrency mining assets; the impact of energy curtailment or regulatory changes in the energy regimes in the jurisdictions in which the Company operates; protection of proprietary rights; the effect of government regulation and compliance on the Company and the industry; network security risks; the ability of the Company to maintain properly working systems; reliance on key personnel; global economic and financial market deterioration impeding access to capital or increasing the cost of capital; share dilution resulting from the ATM Program and from other equity issuances; the construction and operation of facilities may not occur as currently planned, or at all; expansion may not materialize as currently anticipated, or at all; the digital currency market; the ability to successfully mine digital currency; revenue may not increase as currently anticipated, or at all; it may not be possible to profitably liquidate the current digital currency inventory, or at all; a decline in digital currency prices may have a significant negative impact on operations; an increase in network difficulty may have a significant negative impact on operations; the volatility of digital currency prices; the anticipated growth and sustainability of electricity for the purposes of cryptocurrency mining in the applicable jurisdictions; the inability to maintain reliable and economical sources of power for the Company to operate cryptocurrency mining assets; the risks of an increase in the Company's electricity costs, cost of natural gas, changes in currency exchange rates, energy curtailment or regulatory changes in the energy regimes in the jurisdictions in which the Company operates and the adverse impact on the Company's profitability; the ability to complete current and future financings, any regulations or laws that will prevent the Company from operating its business; historical prices of digital currencies and the ability to mine digital currencies that will be consistent with historical prices; an inability to predict and counteract the effects of pandemics on the business of the Company, including but not limited to the effects of pandemics on the price of digital currencies, capital market conditions, restriction on labour and international travel and supply chains; and, the adoption or expansion of any regulation or law that will prevent the Company from operating its business, or make it more costly to do so; and other related risks as more fully set out in the Company's disclosure documents under the Company's filings at www.sec.gov/EDGAR and www.sedarplus.ca.

The forward-looking information in this news release reflects the Company's current expectations, assumptions, and/or beliefs based on information currently available to the Company. In connection with the forward-looking information contained in this news release, the Company has made assumptions about the Company's objectives, goals or future plans, the timing thereof and related matters. The Company has also assumed that no significant events will occur outside of the Company's normal course of business. Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance, and accordingly, undue reliance should not be put on such information due to its inherent uncertainty. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether because of new information, future events or otherwise, other than as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/271906

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in SSRM, over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

October 27, 2025 01:30 ET

 | Source:

Mowi ASA

Mowi ASA hereby invites you to the presentation of the results for the third quarter 2025 at Hotel Continental, Stortingsgaten 24/26, 0117 Oslo, Norway.

The results will be presented in English through a live webcast followed by a Q&A session. Participants will have the opportunity to submit questions online throughout the webcast session. The webcast will be available on http://www.mowi.com/investors/reports/

A recording of the webcast will be made available on our website immediately afterwards.

Please note that the quarterly report and presentation will be published at 06:30 (CET).

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

October 27, 2025 02:00 ET

 | Source:

Pulsar Helium

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS.

CASCAIS, Portugal, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Pulsar Helium Inc. (AIM: PLSR, TSXV: PLSR, OTCQB: PSRHF) (“Pulsar” or the “Company”), a leading helium project development company, is pleased to announce that it has signed a non-binding term sheet to acquire 100% of Hybrid Hydrogen Inc. (“Hybrid”) in an all-share transaction (the “Proposed Transaction”). Hybrid’s primary asset is a lease agreement covering approximately 6,742 acres of mineral rights in Michigan’s Upper Peninsula targeting non-hydrocarbon gases. This strategic acquisition marks Pulsar’s first entry into Michigan, a jurisdiction with a well-established gas regulatory framework now being applied to helium exploration, and forms part of the Company’s broader initiative to expand its Upper Midwest footprint.

Highlights of the Proposed Transaction

Helium-Focused Land Package: Hybrid holds exclusive mineral rights for non-hydrocarbon gases in Michigan’s Upper Peninsula (~6,742 acres). These rights provide Pulsar a foothold in a geologically prospective new region for helium exploration.All-Share, Cash-Preserving Deal: The Proposed Transaction is structured as an all-share deal with a total value of US$80,000 payable in Pulsar common shares. This preserves cash for ongoing work at the flagship Topaz project in Minnesota while enabling strategic expansion.Alignment with Growth Strategy: Expansion into Michigan aligns with Pulsar’s strategy of leveraging Topaz expertise into geologically similar regions.
Thomas Abraham-James, President & CEO of Pulsar, commented:

“This Proposed Transaction provides an exciting opportunity to expand Pulsar’s portfolio into Michigan’s Upper Peninsula, complementing our existing assets and applying our Topaz project expertise to a new prospective region. The potential expansion comes at a pivotal time for Pulsar as we build momentum at Topaz and execute a clear growth vision. An all-share deal allows us to broaden our exploration portfolio while preserving cash for advancing Topaz towards production. In short, this Proposed Transaction aligns perfectly with Pulsar’s strategy of disciplined, high-impact growth in the helium sector.”

Strategic Rationale for the Proposed Transaction

The Michigan mineral rights are situated in a geologic setting analogous to Pulsar’s Topaz helium project in Minnesota. The lease area lies within an ancient sedimentary basin underlain by crystalline basement rocks, similar to the helium-producing Archaean basement found at Topaz. Helium is generated from the decay of uranium and thorium in these basement granites, migrating upward into overlying porous sedimentary reservoirs where it can accumulate beneath impermeable seals.

Through its work at Topaz, Pulsar has developed strong expertise in identifying helium migration pathways, mapping subsurface structures, and recognizing key seals and traps for helium accumulation. Leveraging this experience, Pulsar sees a logical, lower-risk opportunity to identify new helium resources in Michigan’s Upper Peninsula. The Board believes that expanding into geologically familiar regions such as Michigan is a prudent way to grow the portfolio while maintaining technical focus, supported by Michigan’s established regulatory and infrastructure framework.

Terms of the Proposed Transaction

Pulsar has entered into a non-binding term sheet outlining the key terms of the Proposed Transaction. Under the term sheet, Pulsar will acquire 100% of the issued and outstanding shares of Hybrid. The consideration will be satisfied entirely by the issuance of new Pulsar common shares, equivalent to US$80,000 in value. The final number of Pulsar shares to be issued will be determined prior to closing, based on a mutually agreed pricing mechanism (such as a recent volume-weighted average price of Pulsar’s shares). All shares issued as consideration will be subject to a statutory hold period of four months and one day, as required by the TSX Venture Exchange (“TSXV”).

Completion of the Proposed Transaction is subject to customary conditions, including negotiation of a definitive acquisition agreement, satisfactory due diligence, and receipt of all required regulatory and shareholder approvals (including TSXV acceptance). The term sheet provides for an exclusivity period of 60 days for a fee of US$20,000 to finalize definitive documentation and complete due diligence. It is emphasized that the term sheet is non-binding (apart from customary provisions such as confidentiality, and exclusivity), and there is no assurance that a definitive agreement will be reached or that the acquisition will be completed on the terms described.

Hybrid is an early-stage exploration company with no current revenue and no proven reserves or defined helium resources at this time. Accordingly, the acquisition is not expected to have a material near-term impact. However, successful exploration could add significant long-term upside, and Pulsar is confident its technical and operational expertise will maximize this potential over time.

The Company also notes that Neil Herbert, a director of Pulsar, is a minority shareholder of Hybrid, and accordingly abstained from deliberations and voting on this Proposed Transaction, in line with corporate governance best practices.

On behalf Pulsar Helium Inc.
“Thomas Abraham-James”
President, CEO and Director

Further Information:

Pulsar Helium Inc.
[email protected]      
+ 1 (218) 203-5301 (USA/Canada)
+44 (0) 2033 55 9889 (United Kingdom)
https://pulsarhelium.com
https://ca.linkedin.com/company/pulsar-helium-inc.

Strand Hanson Limited
(Nominated & Financial Adviser, and Joint Broker)
Ritchie Balmer / Rob Patrick / Richard Johnson
+44 (0) 207 409 3494

OAK Securities*
(Joint Broker)
Richard McGlashan / Mungo Sheehan
+44 7879 646641 / +44 7788 266844
[email protected] / [email protected]

*OAK Securities is the trading name of Merlin Partners LLP, a firm incorporated in the United Kingdom and regulated by the UK Financial Conduct Authority.

Yellow Jersey PR Limited
(Financial PR)
Charles Goodwin / Annabelle Wills
+44 777 5194 357
[email protected]

About Pulsar Helium Inc.

Pulsar Helium Inc. is a publicly traded company quoted on the AIM market of the London Stock Exchange and listed on the TSX Venture Exchange with the ticker PLSR, as well as on the OTCQB with the ticker PSRHF. Pulsar's portfolio consists of its flagship Topaz helium project in Minnesota, USA, and the Tunu helium project in Greenland. Pulsar is the first mover in both locations with primary helium occurrences not associated with the production of hydrocarbons identified at each.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains forward-looking information within the meaning of Canadian securities legislation (collectively, "forward-looking statements") that relate to the Company's current expectations and views of future events. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as "will likely result", "are expected to", "expects", "will continue", "is anticipated", "anticipates", "believes", "estimated", "intends", "plans", "forecast", "projection", "strategy", "objective" and "outlook") are not historical facts and may be forward-looking statements. Forward-looking statements herein include, but are not limited to, statements relating to the potential impact of the drill results, flow testing and pressure testing on the next iteration of the resource estimate; the potential of CO2 as a valuable by-product of the Company’s future helium production; and the potential for future wells. Forward-looking statements may involve estimates and are based upon assumptions made by management of the Company, including, but not limited to, the Company's capital cost estimates, management's expectations regarding the availability of capital to fund the Company's future capital and operating requirements and the ability to obtain all requisite regulatory approvals. 

No reserves have been assigned in connection with the Company's property interests to date, given their early stage of development. The future value of the Company is therefore dependent on the success or otherwise of its activities, which are principally directed toward the future exploration, appraisal and development of its assets, and potential acquisition of property interests in the future. Un-risked Contingent and Prospective Helium Volumes have been defined at the Topaz Project. However, estimating helium volumes is subject to significant uncertainties associated with technical data and the interpretation of that data, future commodity prices, and development and operating costs. There can be no guarantee that the Company will successfully convert its helium volume to reserves and produce that estimated volume. Estimates may alter significantly or become more uncertain when new information becomes available due to for example, additional drilling or production tests over the life of field. As estimates change, development and production plans may also vary. Downward revision of helium volume estimates may adversely affect the Company's operational or financial performance.

Helium volume estimates are expressions of judgement based on knowledge, experience and industry practice. These estimates are imprecise and depend to some extent on interpretations, which may ultimately prove to be inaccurate and require adjustment or, even if valid when originally calculated, may alter significantly when new information or techniques become available. As further information becomes available through additional drilling and analysis the estimates are likely to change. Any adjustments to volume could affect the Company's exploration and development plans which may, in turn, affect the Company's performance. The process of estimating helium resources is complex and requires significant decisions and assumptions to be made in evaluating the reliability of available geological, geophysical, engineering, and economic date for each property. Different engineers may make different estimates of resources, cash flows, or other variables based on the same available data.

Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company's control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward- looking statements. Such risks and uncertainties include, but are not limited to, that Pulsar may be unsuccessful in completing in drilling commercially productive wells; the uncertainty of resource estimation; operational risks in conducting exploration, including that drill costs may be higher than estimates ; commodity prices; health, safety and environmental factors; and other factors set forth above as well as risk factors included in the Company’s Annual Information Form dated July 31, 2025 for the year ended September 30, 2024 found under Company’s profile on www.sedarplus.ca.

Forward-looking statements contained in this news release are as of the date of this news release, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for the Company to predict all of them or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. No assurance can be given that the forward-looking statements herein will prove to be correct and, accordingly, investors should not place undue reliance on forward-looking statements. Any forward-looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement.